Giving its views on an application filed by Krebs Biochemicals & Industries Ltd, the watchdog also made it clear that such re-classification may be allowed by the stock exchanges under listing norms subject to certain compliances.
Krebs Biochemicals had sought an informal guidance from Sebi on whether shareholders' approval would be required to re-classification of promoter group members to public category.
"Our view is that the company may not be required to obtain approval of the shareholders for the proposed re-classification," Sebi said, adding that its response is based on the information given in the company's letter.
Among others, the company in its letter had submitted that the promoters who want to be re-categorised are "not holding any share in the company and are not holding any control over the affairs and management of the company".
The watchdog also said that its views are expressed with respect to clarification sought in terms of Sebi (Listing obligations and Disclosure requirements) and is not applicable for any other Sebi regulations.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
